| 12509684 |
Compositions and methods for modulating apolipoprotein C-III expression |
Thazha P. Prakash, Punit P. Seth, Mark J. Graham |
2025-12-30 |
|
| 12291709 |
Compositions and methods for modulating apolipoprotein (a) expression |
Thazha P. Prakash, Punit P. Seth, Mark J. Graham |
2025-05-06 |
|
| 12234447 |
Modified compounds and uses thereof |
Punit P. Seth, Michael Oestergaard, Michael T. Migawa, Xue-hai Liang, Wen Shen +1 more |
2025-02-25 |
|
| 12215321 |
Modulators of diacyglycerol acyltransferase 2 (DGAT2) |
— |
2025-02-04 |
|
| 12152244 |
Selective antisense compounds and uses thereof |
Michael Oestergaard, Punit P. Seth |
2024-11-26 |
$9,695,000 |
| 12110491 |
Selective reduction of allelic variants |
C. Frank Bennett, Susan M. Freier, Sarah Greenlee |
2024-10-08 |
$25,378,000 |
| 12091662 |
Compositions for modulating tau expression |
Holly Kordasiewicz, Susan M. Freier, Huynh-Hoa Bui |
2024-09-17 |
$85,831,000 |
| 11959080 |
Methods and compositions for inhibiting PMP22 expression |
Gene Hung, Holly Kordasiewicz, Hien Thuy Zhao |
2024-04-16 |
$50,575,000 |
| 11851655 |
Compositions and methods for modulating apolipoprotein (a) expression |
Thazha P. Prakash, Punit P. Seth, Mark J. Graham |
2023-12-26 |
$60,336,000 |
| 11732261 |
Selective antisense compounds and uses thereof |
Punit P. Seth, Michael Oestergaard |
2023-08-22 |
$11,638,000 |
| 11732265 |
Compositions and methods for modulating complement factor B expression |
Thazha P. Prakash, Punit P. Seth, Tamar R. Grossman, Michael L. McCaleb, Andrew Watt +1 more |
2023-08-22 |
$11,638,000 |
| 11633483 |
Modulators of PCSK9 expression |
Susan M. Freier, Huynh-Hoa Bui |
2023-04-25 |
$22,837,000 |
| 11613752 |
Compositions and methods for modulating PKK expression |
— |
2023-03-28 |
$45,191,000 |
| 11591595 |
Compositions for modulating Tau expression |
Holly Kordasiewicz, Susan M. Freier, Huynh-Hoa Bui |
2023-02-28 |
$103,779,000 |
| 11566245 |
Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
Susan M. Freier |
2023-01-31 |
$53,125,000 |
| 11492615 |
Antisense compounds and uses thereof |
Holly Kordasiewicz, Curt Mazur, Punit P. Seth |
2022-11-08 |
$32,262,000 |
| 11414657 |
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof |
Meghdad Rahdar, Thazha P. Prakash, C. Frank Bennett |
2022-08-16 |
$66,160,000 |
| 11332733 |
Modified compounds and uses thereof |
Punit P. Seth, Michael Oestergaard, Michael T. Migawa, Xue-hai Liang, Wen Shen +1 more |
2022-05-17 |
|
| 11312964 |
Compositions and methods for modulating growth hormone receptor expression |
Thazha P. Prakash, Punit P. Seth, Sanjay Bhanot, Susan M. Freier, Huynh-Hoa Bui |
2022-04-26 |
$26,520,000 |
| 11312962 |
Modulators of diacyglycerol acyltransferase 2 (DGAT2) |
Sanjay Bhanot, Susan M. Freier |
2022-04-26 |
$26,520,000 |
| 11299736 |
Conjugated antisense compounds and their use |
Thazha P. Prakash, Punit P. Seth |
2022-04-12 |
$28,211,000 |
| 11268094 |
5′ modified nucleosides and oligomeric compounds prepared therefrom |
Thazha P. Prakash, Punit P. Seth |
2022-03-08 |
$50,414,000 |
| 11236335 |
Selective antisense compounds and uses thereof |
Michael Oestergaard, Punit P. Seth |
2022-02-01 |
$15,949,000 |
| 11149264 |
Modified compounds and uses thereof |
Punit P. Seth, Michael Oestergaard, Michael T. Migawa, Xue-hai Liang, Wen Shen +1 more |
2021-10-19 |
$42,561,000 |
| 11136577 |
Methods and compositions for inhibiting PMP22 expression |
Gene Hung, Holly Kordasiewicz, Hien Thuy Zhao |
2021-10-05 |
$45,163,000 |
